Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast CancerMin Woo Kim(Kumamoto Health Science University), Yong Serk Park(Yonsei University)TheranosticsJanuary 1, 201910.7150/thno.30228Cited by 125SaveCiteExport RISWatch citationsRelated PapersTumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer|Pharmaceutics|2023|30Clinical value of F-18 FDG PET/CT in staging of hepatocellular carcinoma: Prediction of prognosis by metabolism pattern correlated with extrahepatic metastasis and tumor thrombosis|Journal of Nuclear Medicine|2013|0